Skip to content
healthcare.dev

RIVAROXABAN

NDC 42571-345, RIVAROXABAN, tablet, from Micro Labs Limited.

Product NDC
42571-345
Status
Listed
Labeler
Micro Labs Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208334
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42571-345 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVAROXABAN2.5 mg/1

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
42571-345-0542571034505500 TABLET in 1 BOTTLE (42571-345-05)
42571-345-304257103453030 TABLET in 1 BOTTLE (42571-345-30)
42571-345-604257103456060 TABLET in 1 BOTTLE (42571-345-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/481b7802-5093-43e7-bbd9-1532197eb6e6

Use it

Look up 42571-345 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42571-345 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42571-345. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.